VaccibodyAs Correlations
| VACCDelisted Stock | USD 4.91 0.31 6.74% |
The correlation of VaccibodyAs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VaccibodyAs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VaccibodyAs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Significant diversification
The correlation between VaccibodyAs and NYA is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding VaccibodyAs and NYA in the same portfolio, assuming nothing else is changed.
VaccibodyAs |
The ability to find closely correlated positions to VaccibodyAs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VaccibodyAs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VaccibodyAs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VaccibodyAs to buy it.
Moving together with VaccibodyAs Stock
Moving against VaccibodyAs Stock
| 0.6 | TECO | Teco 2030Asa | PairCorr |
| 0.56 | YAR | Yara International ASA Earnings Call This Week | PairCorr |
| 0.48 | WWI | Wilh Wilhelmsen Holding | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between VaccibodyAs Stock performing well and VaccibodyAs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze VaccibodyAs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MOLN | 2.44 | (0.30) | 0.00 | 1.14 | 0.00 | 4.90 | 23.10 | |||
| MNOV | 2.04 | (0.12) | 0.00 | (0.29) | 0.00 | 4.55 | 14.01 | |||
| ANEB | 2.64 | 0.34 | 0.05 | (0.52) | 3.51 | 6.20 | 20.75 | |||
| CSBR | 2.15 | (0.40) | 0.00 | 10.11 | 0.00 | 4.60 | 11.55 | |||
| CYT | 0.70 | (0.04) | 0.00 | (0.12) | 0.00 | 1.64 | 4.87 | |||
| EWTX | 3.64 | 0.75 | 0.26 | 0.33 | 2.95 | 7.13 | 45.27 | |||
| TALS | 4.50 | 0.77 | 0.08 | 0.69 | 8.16 | 3.48 | 59.33 | |||
| ACET | 3.71 | (0.61) | 0.00 | (0.22) | 0.00 | 5.30 | 29.80 | |||
| CGEM | 2.79 | 0.75 | 0.25 | 0.36 | 2.57 | 7.82 | 23.70 | |||
| VOR | 3.51 | (0.56) | 0.00 | (0.15) | 0.00 | 7.24 | 18.80 |
Delisting Warning - VACC
VaccibodyAs was delisted
| The entity VaccibodyAs with a symbol VACC was delisted from Oslo Stock Exchange. Please try Barinthus Biotherapeutics plc with a symbol BRNS from now on. Check all delisted instruments accross multiple markets. |
VaccibodyAs Corporate Management
Elected by the shareholders, the VaccibodyAs' board of directors comprises two types of representatives: VaccibodyAs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VaccibodyAs. The board's role is to monitor VaccibodyAs' management team and ensure that shareholders' interests are well served. VaccibodyAs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VaccibodyAs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gemma Brown | Chief Officer | Profile | |
| Bernie McDonald | Head IP | Profile | |
| William MBA | CEO Director | Profile | |
| Margaret MD | Chief Officer | Profile | |
| Adrian Hill | CoFounder Advisor | Profile | |
| Sarah Gilbert | CoFounder | Profile | |
| Chris Ellis | Chief Officer | Profile |
Still Interested in VaccibodyAs?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the VaccibodyAs information on this page should be used as a complementary analysis to other VaccibodyAs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in VaccibodyAs Stock
If you are still planning to invest in VaccibodyAs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VaccibodyAs' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |